Omission of RT thoracic wall
•
SUPREMO study (NCT00966888)
www.supremo-trial.com•
Selective Use of Postoperative RadiothErapy after MastectOmy
•
Worldwide study of the NHS- UK:
•
Patients with (y)pT1-2N1 disease; (y)pT1-2N0 with G3 and / or LVI
•
Randomised between
thoracic wall RT or no thoracic wall RT
•
Patients treated with PST were eligible as well
•
Target was 1600 patients; trial closed April 30th 2013, 1688 patients
enrolled
•
Data are maturing…
•
Major contributors: UK (75%), NL (10%)




